Ina Research

Ina Research is a prominent Japanese contract research organization (CRO) that provides comprehensive non-clinical testing services to the pharmaceutical, medical device, and chemical industries. Established in 1974 and based in Nagano, Japan, the company specializes in toxicology, safety pharmacology, and efficacy studies, maintaining high-standard GLP-compliant facilities. They are particularly noted for their extensive experience with non-human primate models and their ability to support global regulatory submissions through advanced data standards like SEND. In 2022, the company was acquired by Shin Nippon Biomedical Laboratories (SNBL), further strengthening its position in the preclinical research market. Ina Research continues to offer specialized services including environmental assessment and laboratory animal supply alongside its core drug development support.